Literature DB >> 11969194

PolC-type polymerase III of Streptococcus pyogenes and its use in screening for chemical inhibitors.

Fude Yang1, Ira B Dicker, Michael G Kurilla, David L Pompliano.   

Abstract

The polC gene from Streptococcus pyogenes (S. pyogenes, strain SF370) has been cloned and expressed in Escherichia coli (E. coli) as a fusion protein containing an N-terminal histidine tag. The purified recombinant enzyme showed an apparent molecular mass of 160 kDa on SDS-PAGE and a specific activity of 3.5 nmol/min/mg when assayed in the presence of calf thymus DNA and the four deoxyribonucleoside triphosphates. This activity was inhibited by TMAU, a specific inhibitor of PolC. To facilitate kinetic studies, and high-throughput assays, a double-stranded oligo DNA primer/template was used as a substrate. The minimum requirement for the length of the substrate was a 20-base oligo primer annealed to a 35-base template. PolC activity was detected either by a filter-binding format or by a novel homogeneous scintillation proximity assay (SPA). Sensitivity to inhibition by anilinouracil analogs was improved by incorporating three deoxycytidines in the template strand as the first 3 bases to be copied by the polymerase. Inhibition of PolC activity by trimethyleneanilinouracil by the filtration and SPA methods gave comparable results, but the SPA assay uses less radioactive label, is less time-consuming, and is amenable to high-throughput formatting. (c)2002 Elsevier Science (USA).

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11969194     DOI: 10.1006/abio.2001.5591

Source DB:  PubMed          Journal:  Anal Biochem        ISSN: 0003-2697            Impact factor:   3.365


  6 in total

1.  Parallel multiplicative target screening against divergent bacterial replicases: identification of specific inhibitors with broad spectrum potential.

Authors:  H Garry Dallmann; Oliver J Fackelmayer; Guy Tomer; Joe Chen; Anna Wiktor-Becker; Tracey Ferrara; Casey Pope; Marcos T Oliveira; Peter M J Burgers; Laurie S Kaguni; Charles S McHenry
Journal:  Biochemistry       Date:  2010-03-23       Impact factor: 3.162

2.  Biological characterization of novel inhibitors of the gram-positive DNA polymerase IIIC enzyme.

Authors:  Alexander Kuhl; Niels Svenstrup; Christoph Ladel; Michael Otteneder; Annegret Binas; Guido Schiffer; Michael Brands; Thomas Lampe; Karl Ziegelbauer; Helga Rübsamen-Waigmann; Dieter Haebich; Kerstin Ehlert
Journal:  Antimicrob Agents Chemother       Date:  2005-03       Impact factor: 5.191

3.  Breaking the rules: bacteria that use several DNA polymerase IIIs.

Authors:  Charles S McHenry
Journal:  EMBO Rep       Date:  2011-04-08       Impact factor: 8.807

Review 4.  Architecture and conservation of the bacterial DNA replication machinery, an underexploited drug target.

Authors:  Andrew Robinson; Rebecca J Causer; Nicholas E Dixon
Journal:  Curr Drug Targets       Date:  2012-03       Impact factor: 3.465

5.  Kinetic characterization of exonuclease-deficient Staphylococcus aureus PolC, a C-family replicative DNA polymerase.

Authors:  Indrajit Lahiri; Purba Mukherjee; Janice D Pata
Journal:  PLoS One       Date:  2013-05-16       Impact factor: 3.240

6.  The β2 clamp in the Mycobacterium tuberculosis DNA polymerase III αβ2ε replicase promotes polymerization and reduces exonuclease activity.

Authors:  Shoujin Gu; Wenjuan Li; Hongtai Zhang; Joy Fleming; Weiqiang Yang; Shihua Wang; Wenjing Wei; Jie Zhou; Guofeng Zhu; Jiaoyu Deng; Jian Hou; Ying Zhou; Shiqiang Lin; Xian-En Zhang; Lijun Bi
Journal:  Sci Rep       Date:  2016-01-29       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.